A LZHEIMER'S disease is the most common cause of severe dementia in the United States, affecting over one million people. 3s44 In the last decade, histopathological studies have implicated degeneration of cortical cholinergic processes as an important feature of this disorder. Autopsy evidence suggests that basal forebrain cholinergic neurons projecting diffusely to the cerebral cortex are lost in Alzheimer's disease, and that degeneration of this population of neurons correlates with marked diminution of cortical cholinergic activity. 6"~2" 37, 47 According to the "cholinergic hypothesis" of Alzheimer's disease, characteristic clinical deficits in memory and learning are a result of inadequate cortical levels of acetylcholine. 6 This hypothesis has provided the rationale for a variety of treatment methods directed at restoring cortical cholinergic function, including systemic 8"9"L9" 33"41"42 and intraventricular ~5"36' 47 pharmacological therapy.
Pharmacological treatment using precursors of acetylcholine synthesis, cholinergic agonists, and acetylcholinesterase (ACHE) inhibitors has largely been disappointing in patients with Alzheimer's disease? "9"~5t~, 33 .3,, The poor functional outcomes and high incidence of adverse side effects may have resulted in part from a lack of regional specificity of these drugs within the brain, since conventional drug delivery systems are incapable of continuously delivering therapeutic agents to selective subregions of the brain. Synthetic polymers have been developed which are capable of releasing biologically active agents in a highly predictable fashion.
Controlled polymeric drug release has been utilized successfully in a variety of medical applications. [23] [24] [25] The copolymer of poly(bis(p-carboxy-phenoxy)propane) anhydride and sebacic acid (PCPP-SA) forms a nontoxic, biodegradable matrix that releases impregnated substances as a result of hydrolytic surface erosion. 24 A 50:50 formulation of polyanhydride:sebacic acid in 3-to 5-u microspheres provides linear release of embedded substances over intervals of 16 to 20 weeks.
This new method of regionally specific neurotransmitter delivery may be useful in the study and treatment of Alzheimer's disease. Hippocampal cholinergic denervation reliably produced profound spatial memory deficits in rats. The cholinomimetic agent bethanechol was impregnated into polyanhydride microspheres and implanted in denervated hippocampus in rats to provide selective local administration of the drug.
Materials and Methods

Fimbria-Fornix Lesions
Twenty-two adult Sprague-Dawley rats, each weighing 250 to 300 gm, were anesthetized with 1.6 ml/kg of intraperitoneal Chloropent (chloral hydrate, magnesium sulfate, pentobarbital, ethyl alchohol, and propylene glycol) and placed in a small-animal stereotactic head frame. Through a midline scalp incision and small bilateral frontoparietal craniectomies, bilateral stereotactic fimbria-fornix transections were performed using a Beaver ophthalmic knife blade mounted on the micromanipulator. For each transection, the tip of the knife blade was placed initially in the midline, 1.5 mm posterior to the bregma and 4.5 mm deep to the cortical surface, then advanced laterally and anteriorly at an angle 30 ~ anterior to the coronal plane for a distance of 5.0 ram. After scalp closure the rats were allowed to recover for 1 week, during which time food and water were provided ad libitum. Two animals were subsequently excluded from analysis when postmortem AChE histochemical studies revealed inadequate fornix lesions.
Radial-Maze Testing
The eight-arm radial maze, as described by Olton and Samuelson, 34 was used to assess spatial memory in the lesioned animals. Prior to initiation of the maze trials, the rats underwent food restriction over a 2-week period until they reached 85% of their baseline weight. During this period of weight reduction, the rats were gradually acclimatized to the radial maze by allowing them to randomly roam the maze surface for short periods of time.
The radial maze consists of an elevated octagonal central platform with eight "choice arms" radiating from the center (Fig. 1) . The maze is placed in a welllighted room with visually prominent objects on all walls. Olton and Samuelson 34 have shown that rats utilize visual features from the surrounding room rather than olfactory cues to spatially orient themselves within M. A. Howard III, et al.
the maze. Sliding doors control access to each choice arm, and at the end of each arm is a food well. During trial runs, a rat is placed on the central platform and food rewards are placed in the food wells. All doors are opened and the rat enters a choice arm and eats the food reward at the end of the arm. When the rat returns to the central platform, all doors are closed for a 5-second period, then simultaneously opened. Rats with intact spatial memory will learn to avoid entering choice arms that no longer have food rewards, and instead select arms which they have yet to enter.
During individual trial runs, the rats in this study were placed on the maze until either all food wells were empty, 10 minutes had elapsed, or a total of 15 arm choices had been made. Between test periods rats were given water ad libitum and supplemental food to maintain body weight at 85% of baseline plus 5 gm/wk for growth. Following 1 week of recovery from fimbriafornix surgery and 1 week of weight reduction, rats were tested on the maze once daily for 2 weeks to determine baseline performance (Fig. 2) .
Bethanechol-Polymer Microspheres
The PCPP-SA was prepared by solvent removal as previously described. 2s Bethanechol was placed in PCPP-SA solution in an organic solvent which was then dispersed as microspheres into silicon oil. The polymer solidified in the silicon oil and was extracted as drugloaded microspheres. Microspheres of the bethanechol-(PCPP-SA) compound ranged in size from 1 to 5 ~ (Fig.  3) . Blank polymer was prepared as described above without impregnated bethanechol. The specimens were stored at -4~ until the time of implantation.
Hippocampal Implants
Rats were anesthetized with inhaled halothane and placed in a small-animal stereotactic head frame. The previous midline scalp incision was reopened and a total of four burr holes were placed, two over each hippocampal formation. Two implants were placed into each hippocampus, either saline (in five rats), blank polymer (in five rats), or bethanechol-impregnated microspheres (in 10 rats). Implant coordinates referenced to the bregma were: 1) 3.3 mm posterior, 1.5 mm lateral, and 3.8 mm ventral; and 2) 5.3 mm posterior, 3 mm lateral, and 3.6 mm ventral.
Microsphere implants were created by placing the powder into a small cone, allowing the powder to settle, then passing a No. 22 blunt-tipped needle into the cone. The microsphere cylinder within the needle was compacted into a length of 1.8 mm by means of a stainless steel stylette. The loaded blunt-tipped needle-stylette assembly was attached to a micromanipulator and directed to the target coordinates described above. Once in the proper position, the stylette was kept stationary to maintain implant position, while the blunt-tipped needle was slowly withdrawn (Fig. 4) . Saline was implanted by drawing up fluid into the distal 1.8 mm of the injection assembly and injecting it into the hippo-F[6. 1. Diagram of the eight-arm radial maze. Choice arms containing food rewards extend out from a central platform. As they learn the task, rats with intact spatial memory recall which arms have already been explored and do not reenter the empty choice arms.
campus using the same technique as was employed with the polymer implants.
Following implantation surgery, all rats resumed daily radial-maze testing. After 40 days of postimplanration testing, rats were deeply anesthetized with intraperitoneal pentobarbital and perfused transcardially with a 10% neutral buffered formalin. The brains were removed and postfixed in 30% sucrose-formalin for 3 days.
Histological Studies
Frozen coronal sections, 40 um thick, were cut from the perfused brains. Alternating sections were processed for cresyl violet staining or AChE histochemistry using Naik's method. 32 To confirm hippocampal cholinergic denervation, AChE-staining densities in hippocampal regions CA 1 through CA4 were analyzed using a Drexel DUMAS microcomputer image analysis system. To control for variability in staining technique between animals, mean AChE optical density in the hippocampus was compared to optical density within the thalamus for each rat. Normal values for AChE optical density were determined by examining hippocampal sections from four unlesioned rats. Two rats with hippocampal AChE-staining density more than 2 standard deviations (SD's) greater than the mean staining density of all lesioned rats were considered to have inadequate fimbria-fornix lesions and were excluded from analysis. Cresyl violet-stained sections were examined to determine the location of the polymer implants and to assess parenchymat changes in the vicinity of the implants.
Statistical Analysis
Radial-maze performance was assessed according to a weighted daily performance scale ( Table 1 ). The prob-FIG. 2. Diagram of experimental design. The rats underwent bilateral fimbria-fornix lesions followed by radial-maze training. After 2 weeks of maze shaping and weight reduction, the rats received hippocampal implants of saline (five rats), blank polymer (five rats), or bethanechol-impregnated polymer (10 rats). Following implantation, the rats were tested for 40 additional days, then sacrificed and processed for histological study.
ability of entering a baited maze arm (correct choice) by chance decreases logarithmically as successive arms are entered, and the weighted score reflects that probability difference. Mean performance scores over 10-day epochs were determined for each animal, beginning with the 10 days preceding polymer implantation. Radial-maze performance was compared between groups as the mean + SD for each 10-day epoch using Student's t-test. Center." The implantation assembly is stereotactically placed into the hippocampal formation. Right: The implantation stylette is held stationary as the stainless steel cylinder is slowly raised, leaving a polymer implant column within the hippocampus.
Results
Histological Findings
The polymer implants were visible by light microscopy in all rats treated with blank or bethanecholimpregnated microspheres. The microspheres maintained their cylindrical configuration wi~thin the brain parenchyma, and a thin rim of reactive glial tissue was noted surrounding the needle track and polymer column (Fig. 5) . A similar pattern of mild gliosis was noted along the implant tracks of rats in the saline-treated group. There was no evidence of hemorrhage in any of the specimens examined. The implant location varied slightly between animals. The majority of implants were contained entirely within the hippocampus, usually extending from the CA1 region into the more ventral CA4 region. However, several implants extended further ventrally into the thalamus.
The AChE histochemical findings revealed widespread loss of hippocampal staining optical density in the fimbria-fornix lesioned rats compared to the unoperated control rats. Figure 6 shows the regional optical density determinations for AChE staining in an unlesioned control versus a lesioned rat. 6 . Photomicrographs of hippocampal sections stained for acetylcholinesterase (ACHE), x 1.25. Specimens are from a rat with a fimbria-fornix lesion (left) and from a control rat (right). The numbers indicate the average regional optical densities for lesioned and control rat groups on the respective photomicrographs. The AChE optical staining densities are markedly decreased in the group with fimbria-fornix lesions compared to the control group, confirming hippocampal cholinergic denervation. fornix lesioning, there was a consistent 50% to 70% reduction in optical density throughout all regions of the hippocampus except the medial portion of CA1, which showed only slight reductions in AChE staining.
M a z e Performance
All rats tolerated the hippocampal implants well and awoke rapidly after halothane anesthesia was discontinued. No difference in general activity level was noted among the various treatment groups. The animals implanted with bethanechol-(PCPP-SA) entered fewer than eight arms in 7.3% of all trials, compared with 8.4% in the blank polymer-treated groups, and 7.0% in the saline-treated group. In the succeeding weeks, the rats treated with saline and blank polymer continued to perform poorly, showing no improvement in performance scores above baseline at any of the time intervals tested (Fig. 7) . As a group, the rats treated with bethanechol-inpregnated microspheres improved significantly following implantation (p < 0.05). Individual performances, however, varied within this improved treatment group; some rats ran the maze without mistakes, while others showed only modest improvement (Fig. 8) . The time course of improvement was rapid, reaching statistical significance during the first 10-day epoch. Beneficial treatment effects persisted for the entire 40 days of the experiment.
Discussion
In this study a new method of intracerebral regional neurotransmitter delivery was utilized to reverse lesioninduced spatial memory deficits in rats with bilateral fimbria-fornix lesions. Implantation of polymer microspheres containing bethanechol into cholinergically denervated hippocampus resulted in improved maze performance in lesioned animals.
Brain histochemical abnormalities involving a variety of neurotransmitters have been reported in patients with Alzheimer's disease. 23916"35"3648 The neurotransmitter system most consistently and profoundly affected, however, is the basal forebrain cholinergic system. ~123744'4v This collection of cholinergic neurons consists of the medial septal nucleus (MSN), the nucleus of the diagonal band of Broca, and the nucleus basalis of Meynert (NBM). In humans as well as in rodents, axons from these basal forebrain neurons project to all regions of the cerebral cortex. The MSN neurons project to the hippocampus by way of the fimbria-fornix, and the NBM neurons project in a   FIG. 7 . Group maze performance scores in the three treatment groups: sham (five saline-treated rats), blank polymer (five rats), and bethanechol-impregnated polymer (10 rats). The vertical axis denotes the mean corrected group performance score over each 10-day epoch _+ standard deviation; the horizontal axis denotes the number of days before and after hippocampal implantation. The performance of the bethanechol-impregnated polymer group shows significant improvement compared to baseline at all postimplant time intervals. Asterisks" indicate statistically significant changes (p < 0.05, Student's t-test). Fl~. 8. Maze performance for 10 individual rats in the group of animals implanted with bethanechol-impregnated microspheres. Several rats displayed marked, unpredictable variability in performance over time. Statistically significant performance variability was noted between some rats in this treatment group. topographical fashion to the frontal, parietal, occipital, and temporal lobes.l'l 3.20,22.26.29,39,45
The "cholinergic hypothesis" of Alzheimer's disease is based on the assumption that loss of basal forebrain cholinergic neurons is the primary pathological process contributing to the cognitive deficits characteristic of this disease. 6 This hypothesis is supported by animal experimental studies showing that selective lesions of the basal forebrain cholinergic system cause cortical cholinergic denervation and impaired memory function. 10.~4,17,~ 8.2~ A variety of treatments have been developed based on this cholinergic hypothesis. 6"8' 9"~7"19"33 Several investigators have reported cortical reinnervation and functional improvement in rodent models of Alzheimer's disease following implantation of cholinergic fetal brain grafts. 4"5' 11' 27 Others report no improvement or deleterious effects following cholinergic grafting. 7 '7 In addition to important neurobiological issues, ethical concerns related to harvesting human fetal tissue may limit the clinical usefulness of this technique. 31 Pharmacological treatments directed toward reversing cholinergic deficits in Alzheimer's disease have included the administration of acetylcholine synthetic precursors, AChE inhibitors, and agents that directly stimulate cholinergic receptors. Although moderate cognitive improvement has been reported in some patients after systemic treatment with these agents, other reports have noted minimal or no improvement. 89"~9"33"4~ '42 One significant drawback to orally or intravenously administered cholinergic drugs is the relatively high incidence of systemic side effects resulting from stimulation of peripheral cholinergic receptors. To circumvent this problem, Harbaugh, et al., 15 continuously infused the cholinergic agonist bethanechol directly into the cerebral ventricles of patients with Alzheimer's disease, with encouraging initial results. Subsequent findings in a larger group of patients, however, showed no improvement in memory function and detrimental effects at the highest doses used. 36 '46 Drugs administered via intraventricular infusion lack regional selectivity for denervated areas of the brain, and this may contribute to poor clinical results. Cholinergic receptors are located throughout the brain and many are not involved with the NBM projection system. 4~ Just as systemic treatment causes detrimental stimulation of peripheral cholinergic receptors, wholebrain administration of bethanechol may excessively stimulate cholinergic receptors in nondenervated regions of the brain.
Regional intracerebral delivery of neurotransmitters using sustained-release polymers may be a useful alternative to these conventional pharmacological methods. A variety of polymers have been synthesized to release biologically active molecules. 23-25 Polyanhydride-sebacic acid copolymer forms a nontoxic matrix which releases embedded substances over time by hydrolytic erosion of the surface. Release kinetics can be engineered in such a way that agents are delivered over time periods ranging from minutes to several months. The 50:50 formulation of PCPP:SA has been shown to be associated with linear release kinetics of embedded substances over periods of 4 to 5 months. The potential medical benefits of polymers have been demonstrated in other applications such as continuous insulin release for the treatment of diabetes, continuous delivery of an immunizing antigen, and delivery of chemotherapeutic agents into brain tumors. 23 Polymeric drug delivery systems have also been used to deliver neuronal tracers 3~ and heparin 26 to perivascular sites. In preliminary experiments, we have characterized the release of radiolabeled acetylcholine from PCPP-SA in rat hippocampus. Approximately 40% of radiolabeled transmitter was released from the polymer in a linear fashion during the 6 weeks following implantation of PCPP-SA microspheres impregnated with 3H-acetylcholine. Diffusion of the tracer was limited to 1 to 2 mm of the adjacent brain parenchyma.
In the current experiment, microspheres of PCPP-SA polymer were impregnated with the AChE-resistant cholinergic agonist bethanechol. The efficacy of this method of regional cholinergic replacement was tested using an animal model of cholinergic denervation. Axons of the medial septal nucleus portion of the basal forebrain cholinergic system travel as a compact fiber bundle in the fimbria-fornix and terminate in the hippocampus. The rodent septohippocampal projection system is easily disrupted surgically, resulting in selective denervation of the hippocampus and reproducible deficits in spatial memory function.l i The hippocampal polymer implantation sites used in the present experiment are comparable to the cholinergic brain grafting sites used by Dunnett, et al., I1 to successfully reverse behavior deficits in rats with fimbria-fornix lesions.
Histological analysis substantiated the stereotactic administration of polymer to the hippocampal sites and showed that the implants retained their cylindrical configuration over time. Host brain reaction was minimal, consisting of a thin concentric ring of gliosis around each implant. This lack of inflammatory response is consistent with previous reports describing a noninflammatory interaction between polymers and corneal tissue. 2~ The exact location of the polymer implants was somewhat variable: most implants were contained within the hippocampus but several extended more ventrally into the thalamus. Because this technical imprecision may contribute to variability in maze performance, an improved technique of intracerebral polymer implantation is currently being developed. Behavioral effects of polymer implants were objectively assessed using an eight-arm radial maze, a paradigm that has been well-characterized and is thought to accurately reflect spatial memory function in the rat. ~4 In the current experiment, rats with bilateral fimbriafornix lesions performed poorly prior to polymer implantation, entering baited and empty choice arms at near-chance frequencies. Following implantation surgery, rats with hippocampal implants of saline or blank polymer showed no improvement during the 6-week testing period. As a group, the rats implanted with bethanechol-impregnated microspheres showed significant improvement in maze performance after implant surgery. This improvement was evident within the first I0 days and persisted for the entire 40-day postimpIantation test period. The magnitude of improvement for individual rats within this treatment group varied: some rats executed the maze task perfectly following implantation, while others showed only moderate improvement. This heterogeneous performance pattern may be a consequence of variability in implant locations, differences in the degree of injury caused by the fimbriafornix lesion surgery, or differences in the quantity of microspheres implanted, among other possible explanations.
An additional caveat must be considered when interpreting the results of the current experiments. Patients with Alzheimer's disease lose cholinergic projections to all regions of the cerebral cortex, while rats with timbria-fornix lesions lose cholinergic projections predominantly to the hippocampus. Although it seems likely that chotinergic intraparenchymal drug delivery will enhance function in other regions of cholinergically denervated brain, this has yet to be proven. This issue will soon be addressed experimentally using rats with lesions of the nucleus basalis. This lesion results in cholinergic denervation throughout the cerebral cortex. ~~
The behavioral effects of cholinergic polymeric implants in several brain regions can be tested using this model.
